teduglutide [rDNA origin] — United Healthcare
Short Bowel Syndrome (SBS)
Initial criteria
- Diagnosis of Short Bowel Syndrome (SBS)
- Dependent on parenteral support
Reauthorization criteria
- Documentation of positive clinical response to Gattex therapy
Approval duration
12 months